Torgunrud A, Davidson B, Nilsen TA, Nitschke Marcussen IK, Dagenborg VJ, Lund-Andersen C, Flatmark K (2026) Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritonei Eur J Surg Oncol, 52 (7), 111873 (in press) DOI 10.1016/j.ejso.2026.111873, PubMed 42119195 Torgunrud A, Lund-Andersen C, Davidson B, Nitschke Marcussen IK, Larsen SG, Dagenborg V, Flatmark K (2025) High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies Pleura Peritoneum, 11 (1), 11-18 DOI 10.1515/pp-2025-0034, PubMed 41868810 Ree AH, Bousquet PA, Visnovska T, Lüders T, Geisler BP, Wang S, Bordin DL, Nilsen HL, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Berg JP, Flatmark K, Meltzer S (2026) Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer Br J Cancer, 134 (8), 1176-1182 DOI 10.1038/s41416-026-03357-6, PubMed 41731117 More publications
